Prostaglandins (PGs) and thromboxanes play a fundamental role in renal physiology. PGs synthesized in the kidney are secreted into the urine by active uptake into the proximal tubule cell, followed by translocation across the luminal membrane. The molecular mechanism of renal PG transport has remained unclear. Our laboratory has identified a cDNA homologue of a recently-cloned organic anion transporter, which we call """"""""OATP-2"""""""", that is expressed in rat kidney. When expressed in cultured mammalian cells or in Xenopus oocytes, OATP-2 catalyzes transport of PGE2 equals approximately PGF2alpha > TxB2>> 6-keto-PGF-1alpha. The Km for PGE2 is approximately 100 nM. Several classic organic anions inhibit OATP-2-mediated PG transport. Thus, OATP-2 is a novel prostaglandin transporter. The long term objective of this five-year proposal is to understand, at a molecular level, the localization, function, structure, and regulation of OATP-2, especially as these pertain to the kidney.
The Specific Aims are to: l. Characterize OATP-2 mRNA expression and clone renal isoforms. 2. Immunologically characterize OATP-2 protein expression. 3. Define the fundamental transport properties of cloned rat OATP-2. 4. Initiate structure-function analysis of OATP-2. 5. Examine the regulation of OATP-2 by kinases and steroid hormones. The proposed experiments are likely to yield fundamental information about the cellular and molecular mechanisms of PG transport in the kidney and other tissues, and about organic anion transport in general.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
General Medicine B Study Section (GMB)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Albert Einstein College of Medicine
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Jerschow, Elina; Edin, Matthew L; Pelletier, Teresa et al. (2017) Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract 5:998-1007.e2
Jerschow, Elina; Ren, Zhen; Hudes, Golda et al. (2016) Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 116:321-328.e1
Schuster, Victor L; Chi, Yuling; Lu, Run (2015) The Prostaglandin Transporter: Eicosanoid Reuptake, Control of Signaling, and Development of High-Affinity Inhibitors as Drug Candidates. Trans Am Clin Climatol Assoc 126:248-57
Schuster, Victor L (2015) The ins and outs of prostaglandin E2 in fever. Temperature (Austin) 2:326-7
Chi, Yuling; Jasmin, Jean-Francois; Seki, Yoshinori et al. (2015) Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice. PLoS One 10:e0131735
Liu, Zhongbo; Benard, Outhiriaradjou; Syeda, Mahrukh M et al. (2015) Inhibition of Prostaglandin Transporter (PGT) Promotes Perfusion and Vascularization and Accelerates Wound Healing in Non-Diabetic and Diabetic Rats. PLoS One 10:e0133615
Chi, Yuling; Suadicani, Sylvia O; Schuster, Victor L (2014) Regulation of prostaglandin EP1 and EP4 receptor signaling by carrier-mediated ligand reuptake. Pharmacol Res Perspect 2:e00051
Lim, Jihyeon; Liu, Zhongbo; Apontes, Pasha et al. (2014) Dual mode action of mangiferin in mouse liver under high fat diet. PLoS One 9:e90137
Chi, Yuling; Min, Jaeki; Jasmin, Jean-Francois et al. (2011) Development of a high-affinity inhibitor of the prostaglandin transporter. J Pharmacol Exp Ther 339:633-41
Chi, Yuling; Schuster, Victor L (2010) The prostaglandin transporter PGT transports PGH(2). Biochem Biophys Res Commun 395:168-72

Showing the most recent 10 out of 37 publications